5-Chlorothiophene-2-carbonyl chloride | CAS:42518-98-9

We serve 5-Chlorothiophene-2-carbonyl chloride CAS:42518-98-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Chlorothiophene-2-carbonyl chloride

Chemical Name:5-Chlorothiophene-2-carbonyl chloride
CAS.NO:42518-98-9
Synonyms:5-Chlorothiophene-2-carbonyl chloride
5-Chloro-2-thenoyl Chloride
5-Chloro-2-thiophenecarbonyl chloride
5-Chloro-thiophene-2-carbonyl chloride
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 223.9±20.0 °C at 760 mmHg
Molecular Formula C5H2Cl2OS
Molecular Weight 181.040
Flash Point 89.2±21.8 °C
 
Specification:
Appearance:Light yellow powder or liquid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rivaroxaban(CAS:366789-02-8).



Contact us for information like 5-Chlorothiophene-2-carbonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloro-thiophene-2-carbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Chloro-2-thenoyl Chloride Use and application,5-Chloro-2-thiophenecarbonyl chloride technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.DL-Ethyl 2-bromobutyrate manufacturer We manufacture APIs and drug manufacturers make medicines from APIs.N-Hydroxymethyl-3,4,5,6-tetrahydrophthalimide supplier From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.